ArticleFrontiers in medicine2023

Biologics targeting IL-17 and IL-23 maintain stability in patients with psoriasis during COVID-19 infection: a case-control study.

Dawei Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.